IRON
Disc Medicine, Inc.
NASDAQ · Healthcare · Biotechnology · US
$79.23
−0.18%Next report
Analyst consensus
- Next report date
- Nov 5, 2026
- EPS estimate
- -$1.65
- Revenue estimate
- $1.9M
Latest reported
- Last report date
- Jul 30, 2026
- EPS actual
- -$1.54
- EPS estimate
- -$1.71
- Revenue actual
- —
- Revenue estimate
- $1.0M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 5
- EPS misses (12Q)
- 7
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -4.4%
- Revenue beats (12Q)
- —
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $102
- PT range
- $85 – $120
- Analysts
- 3
3 Buy0 Hold0 Sell
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 5, 2026